Have a personal or library account? Click to login
Monitoring Multidrug-Resistant Acinetobacter baumannii Infections in the Neurosurgery ICU Using a Real-Time Surveillance System Cover

Monitoring Multidrug-Resistant Acinetobacter baumannii Infections in the Neurosurgery ICU Using a Real-Time Surveillance System

Open Access
|Mar 2022

References

  1. Andrews JM. Determination of minimum inhibitory concentrations. J Antimicrob Chemother. 2001 Jul;48(Suppl 1):5–16. https://doi.org/10.1093/jac/48.suppl_1.5
  2. Arzilli G, Scardina G, Casigliani V, Petri D, Porretta A, Moi M, Lucenteforte E, Rello J, Lopalco P, Baggiani A, et al. Screening for antimicrobial-resistant Gram-negative bacteria in hospitalised patients, and risk of progression from colonisation to infection: Systematic review. J Infect. 2022 Feb;84(2):119–130. https://doi.org/10.1016/j.jinf.2021.11.007
  3. Asif M, Alvi IA, Rehman SU. Insight into Acinetobacter baumannii: pathogenesis, global resistance, mechanisms of resistance, treatment options, and alternative modalities. Infect Drug Resist. 2018 Aug 21; 11:1249–1260. https://doi.org/10.2147/IDR.S166750
  4. Basri R, Zueter AR, Mohamed Z, Alam MK, Norsa’adah B, Hasan SA, Hasan H, Ahmad F. Burden of bacterial meningitis: a retrospective review on laboratory parameters and factors associated with death in meningitis, Kelantan Malaysia. Nagoya J Med Sci. 2015 Feb;77(1–2):59–68.
  5. Chen Y, Ai L, Guo P, Huang H, Wu Z, Liang X, Liao K. Molecular characterization of multidrug resistant strains of Acinetobacter baumannii isolated from pediatric intensive care unit in a Chinese tertiary hospital. BMC Infect Dis. 2018 Dec 4;18(1):614. https://doi.org/10.1186/s12879-018-3511-0
  6. CLSI. Procedures for the handling and processing of blood specimens for common laboratory tests; Approved guideline fourth edition. CLSI document GP44-A4. Wayne (USA): Clinical and Laboratory Standards Institute; 2010.
  7. Correa AAF, Fortaleza CMCB. Incidence and predictors of health care-associated infections among patients colonized with carbapenem-resistant Enterobacteriaceae. Am J Infect Control. 2019 Feb; 47(2):213–216. https://doi.org/10.1016/j.ajic.2018.08.007
  8. Du M, Xing Y, Suo J, Liu B, Jia N, Huo R, Chen C, Liu Y. Real-time automatic hospital-wide surveillance of nosocomial infections and outbreaks in a large Chinese tertiary hospital. BMC Med Inform Decis Mak. 2014 Jan 29;14:9. https://doi.org/10.1186/1472-6947-14-9
  9. Fitzpatrick MA, Suda KJ, Poggensee L, Vivo A, Wirth M, Wilson G, Evans M, Evans CT. Epidemiology and clinical outcomes associated with extensively drug-resistant (XDR) Acinetobacter in US Veterans’ Affairs (VA) medical centers. Infect Control Hosp Epidemiol. 2021 Mar;42(3):305–310. https://doi.org/10.1017/ice.2020.450
  10. Howard A, O’Donoghue M, Feeney A, Sleator RD. Acinetobacter baumannii: an emerging opportunistic pathogen. Virulence. 2012 May 1;3(3):243–250. https://doi.org/10.4161/viru.19700
  11. Huang SS, Yokoe DS, Stelling J, Placzek H, Kulldorff M, Kleinman K, O’Brien TF, Calderwood MS, Vostok J, Dunn J, et al. Automated detection of infectious disease outbreaks in hospitals: A retrospective cohort study. PLoS Med. 2010 Feb 23;7(2):e1000238. https://doi.org/10.1371/journal.pmed.1000238
  12. Isler B, Doi Y, Bonomo RA, Paterson DL. New treatment options against carbapenem-resistant Acinetobacter baumannii infections. Antimicrob Agents Chemother. 2018 Dec 21;63(1):e01110-18. https://doi.org/10.1128/AAC.01110-18
  13. Jiang M, Chen X, Liu S, Zhang Z, Li N, Dong C, Zhang L, Wu H, Zhao S. Epidemiological analysis of multidrug-resistant Acinetobacter baumannii isolates in a tertiary hospital over a 12-year period in China. Front Public Health. 2021 Aug 12;9:707435. https://doi.org/10.3389/fpubh.2021.707435
  14. Kollef KE, Schramm GE, Wills AR, Reichley RM, Micek ST, Kollef MH. Predictors of 30-day mortality and hospital costs in patients with ventilator-associated pneumonia attributed to potentially antibiotic-resistant Gram-negative bacteria. Chest. 2008 Aug; 134(2):281–287. https://doi.org/10.1378/chest.08-1116
  15. Kramer A, Schwebke I, Kampf G. How long do nosocomial pathogens persist on inanimate surfaces? A systematic review. BMC Infect Dis. 2006 Aug 16;6:130 https://doi.org/10.1186/1471-2334-6-130
  16. Landelle C, Legrand P, Lesprit P, Cizeau F, Ducellier D, Gouot C, Bréhaut P, Soing-Altrach S, Girou E, Brun-Buisson C. Protracted outbreak of multidrug-resistant Acinetobacter baumannii after intercontinental transfer of colonized patients. Infect Control Hosp Epidemiol. 2013 Feb;34(2):119–124. https://doi.org/10.1086/669093
  17. Leclère B, Buckeridge DL, Boëlle PY, Astagneau P, Lepelletier D. Automated detection of hospital outbreaks: A systematic review of methods. PLoS One. 2017 Apr 25;12(4):e0176438. https://doi.org/10.1371/journal.pone.0176438
  18. Li YJ, Pan CZ, Fang CQ, Zhao ZX, Chen HL, Guo PH, Zhao ZW. Pneumonia caused by extensive drug-resistant Acinetobacter baumannii among hospitalized patients: genetic relationships, risk factors and mortality. BMC Infect Dis. 2017 May 30;17(1):371. https://doi.org/10.1186/s12879-017-2471-0
  19. Ma MY, Xu J, Yu N, Huang GM. [Analysis of drug resistance of Acinetobacter baumannii and its related factors in ICU] (in Chinese). Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2013 Nov;25(11):686–689. https://doi.org/10.3760/cma.j.issn.2095-4352.2013.11.012
  20. Nasr P. Genetics, epidemiology, and clinical manifestations of multidrug-resistant Acinetobacter baumannii. J Hosp Infect. 2020 Jan; 104(1):4–11. https://doi.org/10.1016/j.jhin.2019.09.021
  21. Nwadike VU, Ojide CK, Kalu EI. Multidrug resistant Acinetobacter infection and their antimicrobial susceptibility pattern in a Nigerian tertiary hospital ICU. Afr J Infect Dis. 2014;8(1):14–18. https://doi.org/10.4314/ajid.v8i1.4
  22. Repizo GD, Viale AM, Borges V, Cameranesi MM, Taib N, Espariz M, Brochier-Armanet C, Gomes JP, Salcedo SP. The environmental Acinetobacter baumannii isolate DSM30011 reveals clues into the preantibiotic era genome diversity, virulence potential, and niche range of a predominant nosocomial pathogen. Genome Biol Evol. 2017 Sep 1;9(9):2292–2307. https://doi.org/10.1093/gbe/evx162
  23. Sebeny PJ, Riddle MS, Petersen K. Acinetobacter baumannii skin and soft-tissue infection associated with war trauma. Clin Infect Dis. 2008 Aug 15;47(4):444–449. https://doi.org/10.1086/590568
  24. Strich JR, Palmore TN. Preventing transmission of multidrug-resistant pathogens in the intensive care unit. Infect Dis Clin North Am. 2017 Sep;31(3):535–550. https://doi.org/10.1016/j.idc.2017.05.010
  25. The Ministry of Public Health. The management standard of report and disposal nosocomial infected outbreak. Gazette Min Health PR China 2009;9:37–39.
  26. Turton JF, Kaufmann ME, Gill MJ, Pike R, Scott PT, Fishbain J, Craft D, Deye G, Riddell S, Lindler LE, et al. Comparison of Acinetobacter baumannii isolates from the United Kingdom and the United States that were associated with repatriated casualties of the Iraq conflict. J Clin Microbiol. 2006 Jul;44(7):2630–2634. https://doi.org/10.1128/JCM.00547-06
  27. Vrancianu CO, Gheorghe I, Czobor IB, Chifiriuc MC. Antibiotic resistance profiles, molecular mechanisms and innovative treatment strategies of Acinetobacter baumannii. Microorganisms. 2020 Jun 21; 8(6):935. https://doi.org/10.3390/microorganisms8060935
  28. Wieland SC, Brownstein JS, Berger B, Mandl KD. Automated real time constant-specificity surveillance for disease outbreaks. BMC Med Inform Decis Mak. 2007 Jun 13;7:15. https://doi.org/10.1186/1472-6947-7-15
  29. Wilks M, Wilson A, Warwick S, Price E, Kennedy D, Ely A, Millar MR. Control of an outbreak of multidrug-resistant Acinetobacter baumannii-calcoaceticus colonization and infection in an intensive care unit (ICU) without closing the ICU or placing patients in isolation. Infect Control Hosp Epidemiol. 2006 Jul;27(7):654–658. https://doi.org/10.1086/507011
  30. Zingg W, Holmes A, Dettenkofer M, Goetting T, Secci F, Clack L, Allegranzi B, Magiorakos AP, Pittet D; Systematic review and evidence-based guidance on organization of hospital infection control programmes (SIGHT) study group. Hospital organisation, management, and structure for prevention of health-care-associated infection: A systematic review and expert consensus. Lancet Infect Dis. 2015 Feb;15(2):212–224. https://doi.org/10.1016/S1473-3099(14)70854-0
DOI: https://doi.org/10.33073/pjm-2022-013 | Journal eISSN: 2544-4646 | Journal ISSN: 1733-1331
Language: English
Page range: 107 - 114
Submitted on: Oct 21, 2021
|
Accepted on: Feb 20, 2022
|
Published on: Mar 30, 2022
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year

© 2022 Yuting Zhu, Mingzhu Ni, Xiaofang Fang, Tonghua Lei, Yan Sun, Reng Ding, Xiuqiong Hu, Chengxiang Bian, published by Polish Society of Microbiologists
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.